Calamos Advisors’s Teladoc Health TDOC Stock Holding History

Calamos Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,729	Closed	-$282K	–	1249
2026 Q1	$282K	Buy	+51,729	New	+$290K	﹤0.01%	1047
2021 Q2	–	Sell	-12,100	Closed	-$2.2M	–	1007
2021 Q1	$2.2M	Sell	12,100 -805	-6%	-$187K	0.01%	681
2020 Q4	$2.58M	Sell	12,905 -11,697	-48%	-$2.38M	0.02%	605
2020 Q3	$5.39M	Buy	24,602 +2,276	+10%	+$482K	0.03%	443
2020 Q2	$4.26M	Buy	22,326 +5,627	+34%	+$986K	0.03%	476
2020 Q1	$2.59M	Sell	16,699 -34,746	-68%	-$4.04M	0.02%	510
2019 Q4	$4.31M	Buy	51,445 +23,936	+87%	+$1.82M	0.02%	543
2019 Q3	$1.86M	Buy	27,509 +5,064	+23%	+$333K	0.01%	613
2019 Q2	$1.49M	Buy	+22,445	New	+$1.31M	0.01%	630
2018 Q4	–	Sell	-27,210	Closed	-$2.35M	–	712
2018 Q3	$2.35M	Buy	27,210 +7,900	+41%	+$563K	0.01%	538
2018 Q2	$1.12M	Buy	+19,310	New	+$943K	0.01%	554

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Calamos Advisors's TDOC Position: Q2 2026 in Review

Calamos Advisors sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 51,729 shares — an estimated $282K sold.

Calamos Advisors first reported a position in TDOC in Q2 2018 and held it in 11 quarters. The position peaked at $5.39M in Q3 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Calamos Advisors reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
Calamos Advisors sold 51,729 Teladoc Health shares in Q2 2026, an estimated $282K.
Calamos Advisors first reported a position in Teladoc Health in Q2 2018 and held it in 11 quarters.
Calamos Advisors's Teladoc Health position peaked at $5.39M in Q3 2020.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.